相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A National Cancer Clinical Trials Network: Recommendations From the Institute of Medicine
Sharyl J. Nass et al.
AMERICAN JOURNAL OF THERAPEUTICS (2011)
Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model
Neil A. Goldenberg et al.
BLOOD (2011)
A Historical Perspective on Clinical Trials Innovation and Leadership Where Have the Academics Gone?
David L. DeMets et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?
J. C. Soria et al.
ANNALS OF ONCOLOGY (2010)
American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
Carmen J. Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care
Neal J. Meropol et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer
B. Sherrill et al.
BRITISH JOURNAL OF CANCER (2008)
Progression-free survival as a surrogate endpoint in advanced breast cancer
Rebecca A. Miksad et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2008)
Progress in Cancer Care: The Hope, the Hype, and the Gap Between Reality and Perception
Leonard B. Saltz
JOURNAL OF CLINICAL ONCOLOGY (2008)
Evolution of the Randomized Controlled Trial in Oncology Over Three Decades
Christopher M. Booth et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Reflections on medical oncology: 25 years of clinical trials - Where have we come and where are we going?
Christopher M. Booth et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer
Tomasz Burzykowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
K-ras mutations and benefit from cetuximab in advanced colorectal cancer
Christos S. Karapetis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Correlation of changes between 2-year disease-free survival and 5-year overall survival in adjuvant breast cancer trials from 1966 to 2006
R. Ng et al.
ANNALS OF ONCOLOGY (2008)
Progression-free survival is a surrogate for survival in advanced colorectal cancer
Marc Buyse et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Cetuximab for the treatment of colorectal cancer
Derek J. Jonker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
End points for colon cancer adjuvant trials: Observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 Randomized trials from the ACCENT group
Daniel J. Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Surrogate end points for median overall survival in metastatic colorectal cancer: Literature-based analysis from 39 Randomized controlled trials of first-line chemotherapy
Patricia A. Tang et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Biomarkers and the design of clinical trials in cancer
Graeme A. M. Fraser et al.
BIOMARKERS IN MEDICINE (2007)
End points for adjuvant therapy trials: Has the time come to accept disease-free survival as a surrogate end point for overall survival?
Sharlene Gill et al.
ONCOLOGIST (2006)
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: Individual patient data from 20,898 patients on 18 randomized trials
DJ Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Surrogate markers and survival in women receiving first-line combination anthracycline chemotherapy for advanced breast cancer
A Hackshaw et al.
BRITISH JOURNAL OF CANCER (2005)
Factors associated with failure to publish large randomized trials presented at an oncology meeting
MK Krzyzanowska et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
On the use of surrogate end points in randomized trials
CB Begg et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY (2000)